Skin Cancer of the Head and Neck

ABSTRACT

The majority of skin cancers of the head and neck are nonmelanoma skin cancers (NMSC). Basal cell carcinoma and squamous cell carcinoma are the most frequent types of NMSC. Malignant melanoma is an aggressive neoplasm of skin, and the ideal adjuvant therapy has not yet been found, although various options for treatment of skin cancer are available to the patient and physician, allowing high cure rate and excellent functional and cosmetic outcomes. Sunscreen protection and early evaluation of suspicious areas remain the first line of defense against skin cancers.

KEYWORDS

Basal cell carcinoma - melanoma - Mohs' micrographic surgery - nonmelanoma skin cancer - squamous cell carcinoma

REFERENCES

• 1 Marks R. An overview of skin cancers. Incidence and causation.  Cancer. 1995;  75(2 Suppl) 607-612
• 2 Buzzell R A. Effects of solar radiation on the skin.  Otolaryngol Clin North Am. 1993;  26 1-11
• 3 Johnson T M, Rowe D E, Nelson B R, Swanson N A. Squamous cell carcinoma of the skin (excluding lip and oral mucosa).  J Am Acad Dermatol. 1992;  26(3 Pt 2) 467-484
• 4 Shumrick K A, Coldiron B. Genetic syndromes associated with skin cancer.  Otolaryngol Clin North Am. 1993;  26 117-137
• 5 Gourin C G, Terris D J. Head and neck cancer in transplant recipients.  Curr Opin Otolaryngol Head Neck Surg. 2004;  12 122-126
• 6 Padgett J K, Hendrix Jr J D. Cutaneous malignancies and their management.  Otolaryngol Clin North Am. 2001;  34 523-553
• 7 Kirkuam N. Tumors and cysts of the epidermis. In: Elder DE, Elenitsas R, Murphy GF, et al. Lever's Histopathology of the Skin. 9th ed. Baltimore, MD; Lippincott Williams & Wilkins 2005: 805-866
• 8 Lo J S, Snow S N, Reizner G T, Mohs F E, Larson P O, Hruza G J. Metastatic basal cell carcinoma: report of twelve cases with a review of the literature.  J Am Acad Dermatol. 1991;  24(5 Pt 1) 715-719
• 9 Salasche S J. Epidemiology of actinic keratoses and squamous cell carcinoma.  J Am Acad Dermatol. 2000;  42(1 Pt 2) 4-7
• 10 Kao G F. Carcinoma arising in Bowen's disease.  Arch Dermatol. 1986;  122 1124-1126
• 11 Rowe D E, Carroll R J, Day Jr C L. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection.  J Am Acad Dermatol. 1992;  26 976-990
• 12 Brown M D. Recognition and management of unusual cutaneous tumors.  Dermatol Clin. 2000;  18 543-552
• 13 Lawenda B D, Thiringer J K, Foss R D, Johnstone P A. Merkel cell carcinoma arising in the head and neck: optimizing therapy.  Am J Clin Oncol. 2001;  24 35-42
• 14 Gloster Jr H M. Dermatofibrosarcoma protuberans.  J Am Acad Dermatol. 1996;  35(3 Pt 1) 355-374 quiz 375-376
• 15 Nelson B R, Hamlet K R, Gillard M, Railan D, Johnson T M. Sebaceous carcinoma.  J Am Acad Dermatol. 1995;  33 1-15 quiz 16-18
• 16 Marenda S A, Otto R A. Adnexal carcinomas of the skin.  Otolaryngol Clin North Am. 1993;  26 87-116
• 17 Greene F L, Page D L, Fleming I D et al. AJCC Cancer Staging Manual 6th ed. Chicago, IL; American Joint Committee on Cancer 2002
• 18 Salasche S J. Status of curettage and desiccation in the treatment of primary basal cell carcinoma.  J Am Acad Dermatol. 1984;  10(2 Pt 1) 285-287
• 19 Brodland D G, Zitelli J A. Surgical margins for excision of primary cutaneous squamous cell carcinoma.  J Am Acad Dermatol. 1992;  27(2 Pt 1) 241-248
• 20 Shriner D L, McCoy D K, Goldberg D J, Wagner Jr R F. Mohs micrographic surgery.  J Am Acad Dermatol. 1998;  39 79-97
• 21 Halpern J N. Radiation therapy in skin cancer. A historical perspective and current applications.  Dermatol Surg. 1997;  23 1089-1093
• 22 Morrison W H, Garden A S, Ang K K. Radiation therapy for nonmelanoma skin carcinomas.  Clin Plast Surg. 1997;  24 719-729
• 23 Kalka K, Merk H, Mukhtar H. Photodynamic therapy in dermatology.  J Am Acad Dermatol. 2000;  42 389-413 quiz 414-416
• 24 Tucker S B, Polasek J W, Perri A J et al.. Long-term follow-up of basal cell carcinomas treated with perilesional interferon alfa 2b as monotherapy.  J Am Acad Dermatol. 2006;  54 1033-1038
• 25 Edwards L, Tucker S B, Perednia D et al.. The effect of an intralesional sustained-release formulation of interferon alfa-2b on basal cell carcinomas.  Arch Dermatol. 1990;  126 1029-1032
• 26 Niles R M. Recent advances in the use of vitamin A (retinoids) in the prevention and treatment of cancer.  Nutrition. 2000;  16 1084-1089
• 27 Rigel D S. Epidemiology and prognostic factors in malignant melanoma.  Ann Plast Surg. 1992;  28 7-8
• 28 Langley R GB, Barnhill R L, Mihn Jr M C. Neoplasms: cutaneous melanoma. In: Freedberg IM, Eisen AZ, Wolff K, et al. Fitzpatrick's Dermatology in General Medicine. 6th ed. New York, NY; McGraw-Hill 2003: 917-947
• 29 Stolz W, Schmoeckel C, Landthaler M, Braun-Falco O. Association of early malignant melanoma with nevocytic nevi.  Cancer. 1989;  63 550-555
• 30 Tannous Z S, Mihm Jr M C, Sober A J, Duncan L M. Congenital melanocytic nevi: clinical and histopathologic features, risk of melanoma, and clinical management.  J Am Acad Dermatol. 2005;  52 197-203
• 31 Sober A J, Chuang T Y, Duvic M Guidelines/Outcomes Committee et al. Guidelines of care for primary cutaneous melanoma.  J Am Acad Dermatol. 2001;  45 579-586
• 32 Elder D E, Elenitsas R, Murphy G F, Xu X. Benign pigmented lesions and malignant melanoma. In: Elder DE, Elenitsas R, Murphy GF, et al. Lever's Histopathology of the Skin. 9th ed. Baltimore, MD; Lippincott Williams & Wilkins 2005: 715-803
• 33 Balch C M, Buzaid A C, Soong S J et al.. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma.  J Clin Oncol. 2001;  19 3635-3648
• 34 Rigel D S, Friedman R J, Kopf A W, Silverman M K. Factors influencing survival in melanoma.  Dermatol Clin. 1991;  9 631-642
• 35 Zitelli J A, Brown C D, Hanusa B H. Mohs micrographic surgery for the treatment of primary cutaneous melanoma.  J Am Acad Dermatol. 1997;  37 236-245
• 36 Wells K E, Rapaport D P, Cruse C W et al.. Sentinel lymph node biopsy in melanoma of the head and neck.  Plast Reconstr Surg. 1997;  100 591-594
• 37 Barth A, Morton D L. The role of adjuvant therapy in melanoma management.  Cancer. 1995;  75(2 Suppl) 726-734
• 38 Hill II G J, Moss S E, Golomb F M et al.. DTIC and combination therapy for melanoma: III. DTIC (NSC 45388) Surgical Adjuvant Study COG PROTOCOL 7040.  Cancer. 1981;  47 2556-2562